vers la météo de la validation par utilisateur
+----------------COMP:V-N(In)---------------+ +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +---MOD_ATT:N-N---+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N-+ | +MOD_ATT:N-N+------SUBJ:V-N-----+--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | In stromal cell from __SP__ bone marrow , deferoxamine mesylate decreases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (__SP__,stromal) MOD_ATT:N-N (__SP__,cell) MOD_ATT:N-N (deferoxamine,bone) MOD_ATT:N-N (deferoxamine,marrowfat) COMP:V-N(In) (decrease,__SP__) SUBJ:V-N (decrease,deferoxamine) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+--------MOD_ATT:N-ADJ--------+ +-------COMP:N-N(of)-------+ | +MOD_ATT:N-A+----------COMP:V-N(In)---------+ | +-MOD_ATT:N-ADJ+ | | +MOD_A+ +------SUBJ:V-N-----+--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | In stromal cell from __SP__ bone marrow , deferoxamine mesylate decreases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (marrowfat,stromal) MOD_ATT:N-ADJ (marrowfat,__SP__) MOD_ATT:N-N (marrowfat,bone) COMP:V-N(In) (decrease,marrowfat) SUBJ:V-N (decrease,deferoxamine) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+--------MOD_ATT:N-ADJ--------+ +-------COMP:N-N(of)-------+ | +------MOD_ATT:N-N-----+----------COMP:V-N(In)---------+ | +-MOD_ATT:N-ADJ+ | | +MOD_A+ +------SUBJ:V-N-----+--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | In stromal cell from __SP__ bone marrow , deferoxamine mesylate decreases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (marrowfat,stromal) MOD_ATT:N-N (marrowfat,cell) MOD_ATT:N-N (marrowfat,bone) COMP:V-N(In) (decrease,marrowfat) SUBJ:V-N (decrease,deferoxamine) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------COMP:N-N(of)-------+ +MOD_ATT:N-A+ | +-MOD_ATT:N-ADJ+ | +MOD_A+ +------SUBJ:V-N-----+--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | In stromal cell from __SP__ bone marrow , deferoxamine mesylate decreases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (marrowfat,__SP__) MOD_ATT:N-N (marrowfat,bone) SUBJ:V-N (decrease,deferoxamine) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+------MOD_ATT:N-N-----+ +-------COMP:N-N(of)-------+ | +MOD_ATT:N-A+----------COMP:V-N(In)---------+ | +-MOD_ATT:N-ADJ+ | | +MOD_A+ +------SUBJ:V-N-----+--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | In stromal cell from __SP__ bone marrow , deferoxamine mesylate decreases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (marrowfat,cell) MOD_ATT:N-ADJ (marrowfat,__SP__) MOD_ATT:N-N (marrowfat,bone) COMP:V-N(In) (decrease,marrowfat) SUBJ:V-N (decrease,deferoxamine) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------COMP:V-N(In)-------------------------------+ | +-------------MOD_ATT:N-N-------------+ | | | +----------MOD_ATT:N-N----------+ | +--MOD_ATT:N-ADJ--+ | | +----MOD_ATT:N-N----+-----------SUBJ:V-N-----------+ | +MOD_ATT:N-+ | | | +MOD_ATT:+-----COMP:N-N(of)-----+ +OBJ:V-+ | | | | | | | | | | | In stromal cell from __SP__ bone marrow , deferoxamine mesylate decreases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (__SP__,stromal) MOD_ATT:N-N (__SP__,cell) MOD_ATT:N-N (decrease,bone) MOD_ATT:N-N (decrease,marrowfat) MOD_ATT:N-N (decrease,deferoxamine) MOD_ATT:N-ADJ (decrease,mesylate) COMP:N-N(of) (decrease,__SP__) COMP:V-N(In) (__NODE__,__SP__) SUBJ:V-N (__NODE__,decrease) OBJ:V-N (__NODE__,mRNA)
+--------MOD_ATT:N-ADJ--------+-------------------------COMP:V-N(In)-------------------------+ | +MOD_ATT:N-A+ +----MOD_ATT:N-N----+-----------SUBJ:V-N-----------+ | | +MOD_A+ | +MOD_ATT:+-----COMP:N-N(of)-----+ +OBJ:V-+ | | | | | | | | | | In stromal cell from __SP__ bone marrow , deferoxamine mesylate decreases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (marrowfat,stromal) MOD_ATT:N-ADJ (marrowfat,__SP__) MOD_ATT:N-N (marrowfat,bone) MOD_ATT:N-N (decrease,deferoxamine) MOD_ATT:N-ADJ (decrease,mesylate) COMP:N-N(of) (decrease,__SP__) COMP:V-N(In) (__NODE__,marrowfat) SUBJ:V-N (__NODE__,decrease) OBJ:V-N (__NODE__,mRNA)
+--------MOD_ATT:N-ADJ--------+-------------------------COMP:V-N(In)-------------------------+ | +------MOD_ATT:N-N-----+ +----MOD_ATT:N-N----+-----------SUBJ:V-N-----------+ | | +MOD_A+ | +MOD_ATT:+-----COMP:N-N(of)-----+ +OBJ:V-+ | | | | | | | | | | In stromal cell from __SP__ bone marrow , deferoxamine mesylate decreases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (marrowfat,stromal) MOD_ATT:N-N (marrowfat,cell) MOD_ATT:N-N (marrowfat,bone) MOD_ATT:N-N (decrease,deferoxamine) MOD_ATT:N-ADJ (decrease,mesylate) COMP:N-N(of) (decrease,__SP__) COMP:V-N(In) (__NODE__,marrowfat) SUBJ:V-N (__NODE__,decrease) OBJ:V-N (__NODE__,mRNA)
+MOD_ATT:N-A+ +----MOD_ATT:N-N----+-----------SUBJ:V-N-----------+ | +MOD_A+ | +MOD_ATT:+-----COMP:N-N(of)-----+ +OBJ:V-+ | | | | | | | | | In stromal cell from __SP__ bone marrow , deferoxamine mesylate decreases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (marrowfat,__SP__) MOD_ATT:N-N (marrowfat,bone) MOD_ATT:N-N (decrease,deferoxamine) MOD_ATT:N-ADJ (decrease,mesylate) COMP:N-N(of) (decrease,__SP__) SUBJ:V-N (__NODE__,decrease) OBJ:V-N (__NODE__,mRNA)
+------MOD_ATT:N-N-----+-------------------------COMP:V-N(In)-------------------------+ | +MOD_ATT:N-A+ +----MOD_ATT:N-N----+-----------SUBJ:V-N-----------+ | | +MOD_A+ | +MOD_ATT:+-----COMP:N-N(of)-----+ +OBJ:V-+ | | | | | | | | | | In stromal cell from __SP__ bone marrow , deferoxamine mesylate decreases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (marrowfat,cell) MOD_ATT:N-ADJ (marrowfat,__SP__) MOD_ATT:N-N (marrowfat,bone) MOD_ATT:N-N (decrease,deferoxamine) MOD_ATT:N-ADJ (decrease,mesylate) COMP:N-N(of) (decrease,__SP__) COMP:V-N(In) (__NODE__,marrowfat) SUBJ:V-N (__NODE__,decrease) OBJ:V-N (__NODE__,mRNA)